Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Sinarmas Multiartha Tbk. (SMMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Sinarmas Multiartha Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Sinarmas Multiartha Tbk. trades at Rp20,175 (market cap 128.47T, 500 24h volume). The key difference: Sinarmas Multiartha Tbk. is far larger — about 780.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (62.5K versus 500). Which is the better fit depends on your goals.
| OBAT | SMMA | |
|---|---|---|
Market Cap | 164.65B | 128.47T |
Volume | 62.5K | 500 |
Lot | 625 | 5 |
Turnover | 15.03M | 10.09M |
Average Price | 240.55 | 20,175 |
Value | 15.03M | 10.09M |
Indicative Equilibrium Price | 238 | — |
Indicative Equilibrium Volume | 100 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Sinarmas Multiartha Tbk.
PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Read more on SMMA →
